about
COPD and stroke: are systemic inflammation and oxidative stress the missing links?Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbiditiesSAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling.IL-17A and serum amyloid A are elevated in a cigarette smoke cessation model associated with the persistence of pigmented macrophages, neutrophils and activated NK cellsApocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice.Recent advances in pre-clinical mouse models of COPD.Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to β-adrenoceptor agonists in mouse lungGlutathione peroxidase-1 as a novel therapeutic target for COPD.Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections.Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia.Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease.Evaluation of right heart function in a rat model using modified echocardiographic views.Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment.Protocols to Evaluate Cigarette Smoke-Induced Lung Inflammation and Pathology in Mice.Increased hypothalamic microglial activation after viral-induced pneumococcal lung infection is associated with excess serum amyloid A production.Modelling COPD co-morbidities in preclinical modelsCSF3R/CD114 mediates infection-dependent transition to severe asthmaClinical utility of pulmonary function and blood biomarker measurementsResolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise ReviewIschaemic stroke in mice induces lung inflammation but not acute lung injuryPrior cigarette smoke exposure does not affect acute post-stroke outcomes in miceNew frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary diseaseIntranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in miceE-Cigarettes: Inducing Inflammation that Spans GenerationsRepurposing matrine for the treatment of hepatosteatosis and associated disorders in glucose homeostasis in miceLipids in Chronic Obstructive Pulmonary Disease: A Target for Future Therapy?Losartan does not inhibit cigarette smoke-induced lung inflammation in miceCigarette smoke extract exacerbates hyperpermeability of cerebral endothelial cells after oxygen glucose deprivation and reoxygenationMatrine reduces cigarette smoke-induced airway neutrophilic inflammation by enhancing neutrophil apoptosisPathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategiesNovel endosomal NOX2 oxidase inhibitor ameliorates pandemic influenza A virus-induced lung inflammation in miceFSTL-1: A New Player in the Prevention of EmphysemaCigarette Smoking Exacerbates Skeletal Muscle Injury without Compromising Its Regenerative Capacity
P50
Q26746530-CC0A0949-584F-4978-8C83-EFE67E796126Q26795662-AAF412C9-DFA6-4DB0-AC6D-60D2FE6C0020Q33576194-78109600-FBFC-4241-9B0E-3BD4104D26F3Q34535911-7820CEB1-6631-431A-98AF-AF0FE5F9F015Q36579569-6518C97B-1195-47FF-9364-A513532A5365Q37426720-39BB1A2F-E912-45B8-82C0-7513842D6155Q37583861-60DB2B86-47A8-40AC-9293-9A924BC74CADQ38121222-58A557B7-9CA7-4F47-B920-883077BDDF81Q38718790-0A0136D0-09F2-4121-8774-796AEFA2E7C9Q38754565-AC5454C3-3B18-4C50-8F7D-071C0DBFE4DFQ38884644-65F9C408-88C4-4B30-ACD5-A477361675F2Q47097924-BCDB7499-6992-4E56-8B99-28CA31CB1EB0Q47127296-5B706A0C-3110-4B19-B980-C474B5ADD044Q47555598-98EFB418-A46F-4CA7-9B80-31E894475872Q55691241-432F6384-0F56-4450-B26C-A18461D46B0EQ57031714-944C4B37-6AE8-4810-B357-B7B1B439DADFQ57480234-AFAEBBD1-9A72-4906-9906-78D284F1AB01Q58590872-84A12D27-0499-467F-BB76-3BB85A89F085Q59136379-67C467F7-D244-4434-9A00-44FA8A8FBCBEQ64059573-E92DF4F2-2143-40E3-96BA-D3DE77950E69Q64067266-455A0EA7-7467-429A-A784-A8652ECCF578Q64118155-F735C17F-B7C6-4160-A484-54314B11D781Q64263180-BF5B2CF6-493F-471F-B2DC-998E51872706Q87918649-ECA46859-B040-49BE-BD02-1EA20752F44AQ89450069-0CEF03C5-CE54-4074-8530-49F250395862Q90438460-0FE1C0AA-8B1E-44A4-801B-29D3ADF5BA04Q90858417-59E42908-096B-4698-BA97-361431CE08B5Q91011983-BF456686-A020-4C2B-B859-B9A0F02400EFQ91409447-3F0EE437-0FC5-46EB-AD94-90BD2A420EDCQ92044310-E7CBF003-2B91-4A26-A091-A61145349B02Q92446475-D9AD7CF4-9FAA-499B-9E1E-5D46372BF6F3Q92493842-349B2538-98AB-437D-BC83-058091926FF3Q92955537-4FE594A3-250D-4087-A8EC-5AC849B20F4B
P50
description
researcher
@en
wetenschapper
@nl
name
Ross Vlahos
@en
Ross Vlahos
@nl
type
label
Ross Vlahos
@en
Ross Vlahos
@nl
prefLabel
Ross Vlahos
@en
Ross Vlahos
@nl
P31
P496
0000-0001-8443-7071